NRX Pharmaceuticals, Inc.
NRXPNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for NRXP. That does not mean none is planned.
Get an email about NRXP's next catalysts
Track NRX Pharmaceuticals (NRXP) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
2 upcoming events in our data (regulatory event, earnings).See the timeline
3 upcoming, 0 past
FDA GDUFA Goal Date Preservative-free Ketamine
ANDA filing. Extracted from SEC filing: EXHIBIT 99.1
FDA approved NRx's ANDA for Preservative-Free Ketamine ahead of the November 10 goal date; product is manufactured via blow-fill-seal technology with Nephron in West Columbia, South Carolina, and contains no benzethonium chloride.
SourceRegulatory Decision - Preservative-Free Ketamine
For Anesthesia and pain control (sterile injectable). NRx Pharmaceuticals announced FDA approval of its ANDA for Preservative-Free Ketamine on October 30, 2026, ahead of the November 10 goal date. The product is manufactured in the US with Nephron and aims to address the ongoing ketamine injection shortage.
SourceNRXP Earnings Report
Date estimated from past reporting pattern, not yet confirmed by the company | EPS Est: $-0.29 | FQ end Sep/2026 | Call: tbd
How NRXP's past catalysts played out
Market Overview
Stock performance and key metrics
No drugs found in this phase.
Frequently asked questions
When is NRX Pharmaceuticals, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for NRX Pharmaceuticals, Inc. (NRXP) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track NRXP biotech catalysts?→
Add NRXP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow NRX Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.